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a  b  s  t  r  a  c  t
There are limited data regarding prevalence of Chlamydia trachomatis infection among north-
ern Brazilian pregnant women.
Objective:  The purpose of this study was to estimate the prevalence of chlamydial infection
among  pregnant women in their third trimester and to determine the repercussion of this
infection  on their offspring.
Methods:  In the ﬁrst phase of this study 100 pregnant women receiving prenatal care in a local
public  university hospital were examined to assess the prevalence of genital C. trachomatis
infection  by polymerase chain reaction technique. In the second phase, 88 pregnant women
were  prospectively evaluated for premature rupture of membranes, puerperal consequences
associated  with chlamydial infection, and neonates were checked for low-birth weight.
Results: The prevalence rate of chlamydial infection was 11%, and 72.7% of the positive par-
ticipants  were predominantly less than 30 years of age (p = 0.1319). A total of 36.4% of the
participants  had premature rupture of membranes (p = 0.9998). Neither low-birth weight
infants  nor preterm delivery were observed. A cohort of 16 newborn babies were followed-
up  up to 60 days of life to ascertain outcome: 50% had respiratory symptoms. Neonates born
to  infected mothers had a higher risk to develop respiratory symptoms in the ﬁrst 60 days
of  life.
Conclusion: The scarcity of data about the effects of chlamydial infection on pregnancy and
neonatal  outcomes justiﬁed this study. Diagnosing and treating chlamydial infection dur-ing  the third trimester of pregnancy may prevent neonate infection. Therefore, preventive
screening  should be seen as a priority for early detection of asymptomatic C. trachomatis
infection  as part of local public health strategies.
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Introduction
Chlamydia trachomatis infection is nowadays considered the
most  frequent sexually transmitted disease (STD) in the devel-
oped  world. The World Health Organization (WHO) estimate
that  annually nearly 100 million new cases occur around the
world.1 Studies show that chlamydial infections is the com-
monest  transmitted bacterial disease in European countries
and  in the United States with more  than 2.8 million new cases
estimated  to occur each year.2 During 2009, more  than 1.2 mil-
lion  cases of chlamydial infection were reported to Centers
for  Diseases Control (CDC). Prevalence of chlamydial infection
was  6.8% among sexually active females aged 14–19 years.3
According to the CDC, C. trachomatis infection among
pregnant women  in the United States is the third main cause
of  STD, with bacterial vaginosis and herpes simplex virus 2
being  ﬁrst and second, respectively.3
In Brazil, according to STDs epidemiologic studies in
speciﬁc  groups of women  that attended gynecology, fam-
ily  planning, and prenatal clinics showed a prevalence of
2.1–27.1%  for genital infection by C. trachomatis.4 In the Ama-
zon  region, there is little data about the actual prevalence of
chlamydial  infections. Only AIDS, HIV in pregnant women and
children,  syphilis in pregnant women, and congenital syphilis
have  compulsory notiﬁcation.5
In Manaus, the capital city of the state of Amazonas (AM),
Brazil,  Alencar et al. established a 27.1% prevalence of chlamy-
dial  infection by direct immunoﬂuorescence technique.6 On
the  other hand, Santos et al. and de Lima Freitas found
20.6% and 52.8% of sexually active women  and infertile
women, respectively, to be positive for Chlamydia using PCR
technique.7,8
Many  studies have provided estimates of chlamydial infec-
tion  in pregnant women  throughout the world. C. trachomatis
disease, considered to be a treatable condition, continues to
infect massive populations and the exact magnitude of this
is  still unknown.9,10 Prevalence rates among pregnant women
vary  enormously around the world.9,11 Jalil et al. conducted
a  study to estimate the prevalence of C. trachomatis infection
in  pregnant women  from six Brazilian cities and found 9.4%
using  hybrid capture technique.12 On the other hand, in For-
taleza,  the capital city of Ceará, Brazil, Martins et al. found a
prevalence  of 11% in pregnant women by PCR technique.13
Uncomplicated C. trachomatis cervicitis in pregnancy may
result  in sporadic and recurrent miscarriage, preterm labor,
premature  rupture of membranes, low birth weight and post-
partum  endometritis.14
Maternal C. trachomatis infections have been associated
with increased morbidity in newborns and infants up to three
months  of age. Approximately two thirds of neonates born
vaginally  to infected mothers will become infected at birth.15
These infections can result in conjunctivitis, otitis media,
pharyngitis and pneumonia in the newborn. Moreover, neona-
tal  infection with C. trachomatis can cause long-term sequelae
such  as chronic obstructive pulmonary disease.14
The primary aim of this study was  to assess the preva-
lence of C. trachomatis in the ﬁnal trimester among pregnant
women  who  attended the low-risk prenatal clinic of a pub-
lic  health university hospital in Manaus, Amazonas, Brazil. 1 3;1  7(5):545–550
In Manaus, there are no studies related to vertical transmis-
sion  of C. trachomatis, so the secondary aim of this study
was  to ascertain possible neonatal implications associated to
maternal C. trachomatis infection. Moreover, the purpose of this
study was  to evaluate C. trachomatis infection rate associated
with  socio-economic status of the participants enrolled in the
study,  adverse pregnancy outcomes associated with miscar-
riage,  preterm labor, premature rupture of membranes and
low  birth weight.
Materials  and  methods
Endocervical samples were  collected from 100 pregnant
women receiving care at the low-risk prenatal clinic of Dona
Francisca  Mendes University Hospital in Manaus, Amazonas,
Brazil,  between January and June 2005. The ﬁrst phase of
this  study was  a cross-sectional evaluation of the prevalence
of  Chlamydia infection in the ﬁnal trimester of pregnancy
(as  of 29 weeks of gestation). In the second phase of this
study,  pregnant women were prospectively followed to eval-
uate  postpartum effects of this infection as well as upon their
neonates  up to sixty (60) days after birth.
This study was  approved by the Human Research Ethics
Committee at the Federal University of Amazonas and per-
formed  in accordance with the Declaration of Helsinki.
Assessment  of  patients
Pregnant women included in this study answered a stan-
dardized  questionnaire to collect information on age, marital
status  and medical history, number of lifetime sexual part-
ners  and socio-economic status. Family income and education
level  were the criteria used to determine socio-economic sta-
tus.  Patients were  excluded if the gestational age was  less than
28  weeks and six days, had infections requiring antibiotic ther-
apy  or a history of antibiotic use in the preceding 30 days.
In  addition, pregnant women  who had sexual intercourse in
the past 72 h, history of vaginal bleeding or who  used vaginal
cream,  suspected premature rupture of the membranes, and
a  diagnosis of placenta previa were also excluded.
In the ﬁrst phase of the study all participants were  con-
tacted  by telephone so that the researchers could collect
information about their maternity admission and start the
second  phase of the study. During the second phase of the
study  88 pregnant women  who met  the eligibility criteria had
their  delivery checked and were followed-up for 60 days after
giving  birth. Of a total of 100 participants in the ﬁrst phase
of  the study 12 were  excluded from the study: four could not
be  contacted and eight due to insufﬁcient follow-up time (less
than  40 days of postpartum).
A  cohort study was carried out in 88 newborns who  were
evaluated in the ﬁrst 24 h and monitored thereafter every 15
days  up to 60 days of life. However, 12 neonates were excluded
due  to loss of contact (four) and to follow-up time less than 60
days  of life (eight). Moreover, one case of stillbirth occurred.
Subsequent evaluations were conducted by telephone and if
some ocular discharge or respiratory symptoms appeared in
the neonate a clinical evaluation was  requested. Furthermore,
patient’s complaints, clinical evaluation and physical exams



















































Table 1 – Speculum examination according to PCR
results for C. trachomatis in pregnant women  in Manaus,
Amazonas, Brazil.
Speculum examination PCR for Chlamydia trachomatis Total
Positive Negative
(n  = 11) (n = 89)
n % n %
Cervicitis 0.0193
Yes 4 36.4 7 7.9
No 7 63.6 82 92.1
Endocervical secretion 0.0411
Yes 7 63.6 25 28.1
No 4 36.4 64 71.9
Table 2 – Premature rupture of membranes in pregnant
women  according to PCR results for Chlamydia




PCR  for Chlamydia trachomatis Total
Positive Negative
n % n %
Yes 4 36.4 32 41.6 36b r a z j i n f e c t d i s .
ere  registered in the questionnaire and entered in Epi-Info
ata  bank.
ollection  of  the  samples
ndocervical material for smears was  collected using a cyto-
rush  and subsequently re-suspended in 400 L of TE (10 mM
ris–HCl  pH 8.0 and 1 mM EDTA) and stored at −20◦ C until
NA  extraction.
reparation  of  the  samples  for  PCR
ach sample was  supplemented with 400 L TPK solution [TE,
0%  Tween, 10 mg/mL  proteinase K], followed by incubation at
6◦ C for 1 h and then boiling for 10 min. DNA from samples
hat  contained blood was  extracted by phenol/chloroform.
CR  ampliﬁcation  of  C.  trachomatis  DNA  plasmid
he KL1 (5′TCCGGAGCGAGTTACGAAGA3′) and KL2
3′AATCAATGCCCGGGATTGGT5′) primers were  used to
mplify  a 241 bp fragment of the C. trachomatis DNA plasmid
y  PCR. The PCR consisted of 5.0 L of DNA; 5.0 L of 10×
CR  buffer; 2.0 L of 50 mM MgSO4; 1.0 L of 10.0 mM dNTP;
.0  L of each primer (5 pmol/L); 0.2 L of 5 U/L Taq DNA
olymerase; and 26.8 L Milli-Q water to complete the 50 L
olume.  The ampliﬁcation was  performed in a PXE 0.2 Ther-
al  Cycler (Thermo Electron Corporation), using the following
rogram  with 40 ampliﬁcation cycles: pre-denaturing at 94 ◦C
or  30 s, denaturation at 94 ◦C for 30 s, primer annealing at
4 ◦C for 30 s and primer extension at 68 ◦C for 2 min, followed
y  a ﬁnal extension at 68 ◦C for 5 min.
NA  sequencing
o conﬁrm the presence of 241 bp PCR products, we sequenced
ositive  samples of C. trachomatis with the MegaBACE 1000
NA  Analysis System. The ampliﬁed products were digested
ith  EXO and SAP enzymes, followed by incubation at
7 ◦C and 80 ◦C for 1 h and 30 min, respectively. The puri-
ed  products were  sequenced using DYEnamic ET DYE
erminator Cycle Sequencing kit for MegaBace from GE
ealthcare Lifesciences according to manufacturer’s protocol.
he  sequencing reactions were  separated and analyzed on the
utomatic  sequencer.
tatistical  analysis
tatistical analyses were  performed to calculate the absolute
nd  relative frequency distributions for qualitative variables;
s  well as median and standard deviation values for quan-
itative  variables. The data were  analyzed to evaluate the
ssociation between the categorical variables and PCR results
sing  the Pearson 2 test with the Yates correction or Fisher’s
xact  test. To analyze the risk factors of the neonates rela-
ive  risks (RR) were  calculated. Student’s t-test was  used to
ompare  means of normally distributed data. To estimate the
revalence  of C. trachomatis in pregnant women a 95% con-
dence  interval [CI] was  calculated. Throughout this study,
 < 0.05 was  considered signiﬁcant. Statistical analysis wasNo  7 63.6 45 58.4 52
Total 11 12.5 77 87.5 88
performed using the Epi-Info version 3.3 software for Win-
dows,  developed and distributed by CDC, Atlanta, GA, USA.
Results
Phase  I  –  study
Out of 100 patients 11 (11.0%) were C. trachomatis-positive by
PCR.  The mean age of PCR-positive patients was 23.5 years
with  a standard deviation of ±4.5 years.
Although we  assessed associations between C. trachomatis
infection with family income (45.5%) and their educational
level (45.5%), no statistically signiﬁcant association could be
found.
Endocervical  secretion and cervicitis were  observed in
63.6%  and 36.4%, respectively, among those women  posi-
tive  for C. trachomatis infection. Both endocervical secretion
and  cervicitis were signiﬁcantly associated with C. tracho-
matis  infection (p = 0.0411 and 0.0193, respectively) as shown
in  Table 1.
Phase  II  study  –  maternal  and  perinatal  data
There was  no signiﬁcant association between positivity for
C.  trachomatis infection and premature rupture of membranes
(Table  2). Neither preterm labor (less than 37 weeks gestational
age)  and nor low-birth weight (weight less than 2500 g/5.5
pounds)  was  observed among the PCR-positive women.
Cesarean delivery was indicated for PCR-positive prim-
iparous  pregnant woman. Chronic tubal sequelae were
548  b r a z j i n f e c t d i s . 2 0 1 3;1  7(5):545–550
Table 3 – Incidence of respiratory symptoms in a cohort
of  87 neonates exposed according to maternal Chlamydia




Respiratory  symptoms Total
Yes No
n % n %
Yes 8  50.0 2 2.8 10
No  8 50.0 69 97.2 77
Total 16 18.4 71 81.6 87
Table 5 – Mode of delivery and respiratory symptoms of
neonates  in Manaus, Amazonas, Brazil.
Mode of delivery Respiratory symptoms Total
Yes No
n % n %
Cesarean section 7 43.8 29 40.8 36
presenting  chlamydial infection is two times higher in underRR = 7.7; 95% CI (3.7–15.9).
assessed by the surgery description. One week after birth a
patient  was  readmitted to the hospital with diagnosis of post-
natal  endometritis. Another C. trachomatis positive participant
gave  birth to a stillborn fetus with 34 weeks gestation. After
this  episode, this patient developed postnatal endometritis.
Cohort  study  of  neonatal  outcome
Of the 87 newborns, 16 (18.4%) presented respiratory symp-
toms.  Of these newborns, eight (50%) were  born to C.
trachomatis-positive mothers evidencing a RR of 7.7 (Table 3).
Moreover, neonates born to positive mothers were more
likely  to develop respiratory symptoms such as nasal obstruc-
tion  (RR = 6.7), coryza (RR = 7.7), cough (RR = 27.0) and dyspnea
(RR  = 15.4) (CI 95%) (Table 4). There was  no statistically signif-
icant  (p = 0.8312) association between C. trachomatis infection
and  type of delivery (cesarean section or vaginal) (Table 5).
Discussion
Studies show that C. trachomatis infection during pregnancy
may  lead to serious complications. Epidemiological data sug-
gest  that pregnant women  may  be a speciﬁc target group
for  C. trachomatis screening. Antenatal screening, as rec-
ommended by the CDC,3 would be beneﬁcial to decrease
morbidity amongst women  themselves, but also to prevent
vertical  (infant) and horizontal (partner) transmission.
Table 4 – Incidence of nasal obstruction, coryza, cough and dys





Yes No Total Yes  No T
n % n % n % n % 
Yes 5 50.0 5 6.5 10 7 46.7 3 4.2 1
No 5 50.0 72 93.5 77 8 53.3 69 95.8 7
Total 10 77 85.5 87 15 17.2 72 82.8 8
a RR = 7.7; 95% CI (2.7–22.0).
b RR = 6.7; 95% CI (3.1–14.6).
c RR = 27.0; 95% CI (6.5–112.2).
d RR = 15.4; 95% CI (1.2–565.5).Vaginal 9 56.2 42 59.2 51
Total 16 18.4 71 81.6 87
Although studies have demonstrated prevalence of C. tra-
chomatis  in pregnant women using hybrid capture technique in
Brazilian cities,12 we  decided to undertake this study using the
conventional  PCR technique. However, although hybrid cap-
ture  technique is widely used for the detection of pathogens, it
may lack sensitivity in comparison with PCR techniques.16 PCR
was  the ﬁrst technique to be developed and because of its abil-
ity  to amplify speciﬁc targets and due to superior sensitivity it
remains the most widely used molecular technique.17
The prevalence of C. trachomatis infection in this study was
11.0%.  Although Jalil et al.12 found a prevalence of 9.4% among
Brazilian  pregnant women, the rate identiﬁed in this study
is  in agreement with the ﬁndings of Martins et al.13 (11.0%).
However, as mentioned above there were no data on C. tracho-
matis  infection among pregnant women in the city of Manaus
before  this study. The main goal of this study was  to better
understand the epidemiology of Chlamydia infection in this
Brazilian  city. As compared to other C. trachomatis infection
prevalence studies conducted in Brazil, it is possible that the
prevalence  rate identiﬁed in this study is associated with the
population  characteristic. Although we found that the major-
ity  (45.5%) of the participants with PCR-positive results had a
low family income, in addition to low educational level (45.5%),
and  had no knowledge of the existence of C. trachomatis and
its  effects on women’s reproductive health. A total of 81.8%
of  PCR-positive C. trachomatis women in this study were  mar-
ried  or were  living a cohabitating situation. Only one lifetime
sexual  partner was reported by 90.9% of the women; 72.7% of
the  PCR-positive patients were under 25 years old. The risk of25  years old women.18 In most of the studies the majority of
positive  participants were under 25 years old, which is could
possibly  be explained by the unhealthy lifestyle behavior of
pnea in a cohort of neonates according to maternal
aus, Amazonas, Brazil.
Coughc Dyspnoead
otal Yes No Total Yes  No Total
n % n % n % n %
0 7 77.8 3 3.8 10 2 66.7 8 9.5 10
7 2 22.2 75 96.2 77 1 33.3 76 90.5 77
7 9 10.3 78 89.7 87 3 3.4 84 96.6 87
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his age group, such as unprotected sex.19 These factors may
e  due to high number of unrecognized infected men which
rovides  a reservoir for spreading the infection to women via
exual  contact.20 These ﬁndings indicate the need for dis-
eminating information about the risk factors for Chlamydia
nfection. The following factors may  be responsible for the
nadequate  incorporation of preventive measures by women:
ow  educational level of the population; and lack of screening
or  Chlamydia infection in the public health system.21 Also,
t  is possible that the prevalence rate identiﬁed in this study
s  associated with low socio-economic status and low family
ncome  of the participants enrolled in this study. Women  of
ow-income  groups or of low educational level have no access
o  screening tests.
Considering  that 36.4% of the PCR-positive patients had
ervicitis  identiﬁed at gynecological examination, this is an
mportant  clinical ﬁnding for women’s reproductive health
ecause  in certain situations, cervicitis may  ensue infection
n  pregnancy, which may  result in preterm labor and neonatal
nfections.  This clinical ﬁnding is in agreement with the syn-
romic  approach protocol for vaginal discharge and cervicitis
stablished by CDC.22 Considering that chlamydial infections
re  usually asymptomatic and therefore difﬁcult to screen,
omen  without such marker would be considered to be at
igh  risk of ascending infection, which may  lead to severe
omplications resulting in tubal damage.23
In this study, we  veriﬁed a high rate of abortion. In contrast
o  most studies on the subject, 30 (90.9%) of these participants
ere  negative for C. trachomatis infection. Although various
tudies  state that C. trachomatis may  cause abortion in sev-
ral  animal species, endocervical Chlamydia infections may  or
ay not be associated with spontaneous abortion.24,25 This
iagnostic accuracy is important because it has the poten-
ial  to help identifying cases at higher risk for spontaneous
bortion.
In  this study, we  veriﬁed a case of a pregnant woman diag-
osed  with Chlamydia infection developed a stillborn fetus.
he  putative association with the infection could not be con-
rm  because the fetus was  investigated. Andrews et al.26
elated a study where chlamydial infection detected at 24-
eek  gestation could be associated with double risk of preterm
irth.  Yet, infection that was  detected at 28-week gestation
ad  no signiﬁcant effect of preterm birth.
Also, some studies indicate that C. trachomatis is an
mportant etiological agent of endometritis in women  with
oncomitant  signs of salpingitis.27 It is possible that cases
f  postpartum endometritis in this study were  due to C. tra-
homatis  infection. Ascending infections of the female genital
ract  with sexually transmitted agents of the lower genital
ract  may  occur during the postpartum period.28
In this study, 50% of positive C. trachomatis newborns
resented respiratory problems. Various studies state that
ransmission of C. trachomatis from mothers to their new-
orns  usually occurs at the time of delivery with passage of
he  newborn through the infected endocervix. According to
umazaki et al. and Schaad et al. the possibility of intrauter-
ne  infection at late pregnancy has also been reported.29ur ﬁnding showed a relation between C. trachomatis infec-
ion  and respiratory symptoms. Cough symptoms showed to
ave an increased risk (RR 27.0) when neonates are born to3;1 7(5):545–550  549
infected mothers, followed by dyspnea (RR 15.4), coryza (RR
7.7)  and nasal obstruction (RR 6.7). Respiratory symptoms were
more  frequent in neonates born to Chlamydia infected moth-
ers.  In addition, in this study, respiratory symptoms such as
cough,  was the most important symptom found in infants.
Therefore, it is clear that clinical ﬁndings in this study in
neonates  born to Chlamydia infected mothers were  associated
with  antenatal chlamydial infection in their mothers. Bébéar
and  Barbeyrac have also described that untreated infection
acquired at birth can persist for months or years.30 Moreover,
the  role of chlamydial infection resulting in neonatal pneumo-
nia  has also been considered. Although mortality associated
to  neonatal pneumonia caused by chlamydial infection is
low,  sequelae such as impairment in lung function may  be
evidenced.14 These ﬁndings indicate the great importance of
a  systematic investigation for this curable STD in pregnant
women. This points to the necessity of an important clinical
measure  to reduce vertical transmission and complications of
C.  trachomatis infection and other causes of curable STD.
Conclusion
Our results demonstrate a true local reality, where women
lack  information about Chlamydia infection and an awareness
of  the possibility of gestational, perinatal and neonatal com-
plications.  Most of the time, pregnant women  who  are less
privileged  in socioeconomic and educational terms are left
without  any or insufﬁcient medical assistance. It is impor-
tant  to emphasize the need for an equitable distribution of
resources  in health services. Therefore, it is essential to imple-
ment  antenatal screening programs  in public health service
laboratories using the PCR method for detecting Chlamydia
infection in this high risk population during the last month
of  pregnancy.
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